Here are the staff publications for June 2023.

Compiled by the Health Sciences Library (RMH, RWH, PMCC & Victorian Mental Health) 5th July 2023.

1. Alfitian J, Basto J, Miestereck J, Ismail H, Ho KM, Kammerer T, Schick V, Riedel B, Schier R. End-tidal carbon dioxide in the early phase of cardiopulmonary exercise testing prior to major colorectal cancer surgery associates with postoperative outcome. Minerva Anestesiol 2023;89:536-45.
2. Ayers KL, Eggers S, Rollo BN, Smith KR, Davidson NM, Siddall NA, Zhao L, Bowles J, Weiss K, Zanni G, Burglen L, Ben-Shachar S, Rosensaft J, Raas-Rothschild A, Jørgensen A, Schittenhelm RB, Huang C, Robevska G, van den Bergen J, Casagranda F, Cyza J, Pachernegg S, Wright DK, Bahlo M, Oshlack A, O'Brien TJ, Kwan P, Koopman P, Hime GR, Girard N, Hoffmann C, Shilon Y, Zung A, Bertini E, Milh M, Ben Rhouma B, Belguith N, Bashamboo A, McElreavey K, Banne E, Weintrob N, BenZeev B, Sinclair AH. Variants in SART3 cause a spliceosomopathy characterised by failure of testis development and neuronal defects. Nat Commun 2023;14:3403.
3. Ayers KL, Eggers S, Rollo BN, Smith KR, Davidson NM, Siddall NA, Zhao L, Bowles J, Weiss K, Zanni G, Burglen L, Ben-Shachar S, Rosensaft J, Raas-Rothschild A, Jørgensen A, Schittenhelm RB, Huang C, Robevska G, van den Bergen J, Casagranda F, Cyza J, Pachernegg S, Wright DK, Bahlo M, Oshlack A, O'Brien TJ, Kwan P, Koopman P, Hime GR, Girard N, Hoffmann C, Shilon Y, Zung A, Bertini E, Milh M, Ben Rhouma B, Belguith N, Bashamboo A, McElreavey K, Banne E, Weintrob N, BenZeev B, Sinclair AH. Author Correction: Variants in SART3 cause a spliceosomopathy characterised by failure of testis development and neuronal defects. Nat Commun 2023;14:3566.
4. Beadell I, Byun M, Feller H, Ferrie M, Best S. Co-designing interventions to 'live well': experiences and perceptions of the Genetic, Undiagnosed and Rare Disease (GUaRD) community. J Community Genet 2023;14:295-305.
5. Beer H, Chung H, Harrison SJ, Quach H, Taylor-Marshall R, Jones L, Krishnasamy M. Listening to What Matters Most: Consumer Endorsed Patient Reported Outcome Measures (PROMs) for Use in Multiple Myeloma Clinical Trials: A Descriptive Exploratory Study. Clin Lymphoma Myeloma Leuk 2023;23:505-14.
6. Berger D, Van Dyk S, Beaulieu L, Major T, Kron T. Modern Tools for Modern Brachytherapy. Clin Oncol (R Coll Radiol) 2023;35:e453-e68.
7. Bonfiglio S, Sutton LA, Ljungstrom V, Capasso A, Pandzic T, Westrom S, Foroughi-Asl H, Skaftason A, Gellerbring A, Lyander A, Gandini F, Gaidano G, Trentin L, Bonello L, Reda G, Bodor C, Stavroyianni N, Tam CS, Marasca R, Forconi F, Panayiotidis P, Ringshausen I, Jaksic O, Frustaci AM, Iyengar S, Coscia M, Mulligan SP, Ysebaert L, Strugov V, Pavlovsky C, Walewska R, Osterborg A, Cortese D, Ranghetti P, Baliakas P, Stamatopoulos K, Scarfo L, Rosenquist R, Ghia P. BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib. Blood Adv 2023;7:2794-806.
8. Brown LM, Ekert PG, Fleuren EDG. Biological and clinical implications of FGFR aberrations in paediatric and young adult cancers. Oncogene 2023;42:1875-88.
9. Bruessel P, Concannon E, Snow H, Zinn R. Islanded SCIP flap after sarcoma resection: a novel approach for Mons pubis defects. ANZ J Surg 2023;93:1728-30.
10. Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S, Investigators MP. Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol 2023;41:3339-51.
11. Churchill ML, Holdsworth-Carson SJ, Cowley KJ, Luu J, Simpson KJ, Healey M, Rogers PAW, Donoghue JF. Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis. Biomolecules 2023;13.
12. Claridge Mackonis ER, Hardcastle N, Haworth A. A survey of compliance with stereotactic ablative body radiotherapy quality recommendations. J Med Imaging Radiat Oncol 2023;67:435-43.
13. Cliff ERS, Reynolds G, Grigg A. Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma. Clin Hematol Int 2023;5:71-7.
14. Cooper WA, John T. Rethinking Biomarkers for Combination Chemoimmunotherapy. J Thorac Oncol 2023;18:841-3.
15. Czosnek L, Rankin NM, Cormie P, Murnane A, Turner J, Richards J, Rosenbaum S, Zopf EM. "Now is the time for institutions to be investing in growing exercise programs as part of standard of care": a multiple case study examining the implementation of exercise oncology interventions. Support Care Cancer 2023;31:422.
16. de Botton S, Fenaux P, Yee K, Recher C, Wei AH, Montesinos P, Taussig DC, Pigneux A, Braun T, Curti A, Grove C, Jonas BA, Khwaja A, Legrand O, Peterlin P, Arnan M, Blum W, Cilloni D, Hiwase DK, Jurcic JG, Krauter J, Thomas X, Watts JM, Yang J, Polyanskaya O, Brevard J, Sweeney J, Barrett E, Cortes J. Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML. Blood Adv 2023;7:3117-27.
17. Field KR, Wragg KM, Lee WS, Rigau M, Uldrich AP, Kent SJ, Juno JA. Cytokines enhance human Vgamma9Vdelta2 T-cell TCR-dependent and TCR-independent effector functions. Eur J Immunol 2023;53:e2250220.
18. Fionda B, Pagliara MM, Chyrek AJ, Guix B, O'Day RFJ, Fog LS, Martínez-Monge R, Tagliaferri L. Ocular Brachytherapy (Interventional Radiotherapy): Preserving the Vision. Clin Oncol (R Coll Radiol) 2023;35:e445-e52.
19. Forbes Shepherd R, Bradford A, Lieschke M, Shackleton K, Hyatt A. Patient communication and experiences in cancer clinical drug trials: a mixed-method study at a specialist clinical trials unit. Trials 2023;24:400.
20. Gambacorta MA, Chiloiro G, Masciocchi C, Mariani S, Romano A, Gonnelli A, Gerard JP, Ngan S, Rödel C, Bujko K, Glynne-Jones R, van Soest J, Dekker A, Damiani A, Valentini V. pCR and 2-Year Disease-Free Survival: A Combination of the Two Endpoints as a New Classification for Locally Advanced Rectal Cancer Patients-An Updated Pooled Analysis of Eleven International Randomized Trials. Cancers (Basel) 2023;15.
21. Hawke JA, Apte SS, Yeung TM, Pham T, Guerra G, Heriot AG, Warrier SK. Open pelvic sidewall excision utilizing an extended lateral plane with excision of the sciatic nerve and ischial spine for recurrent rectal cancer. ANZ J Surg 2023;93:1704-6.
22. Kast K, John EM, Hopper JL, Andrieu N, Noguès C, Mouret-Fourme E, Lasset C, Fricker JP, Berthet P, Mari V, Salle L, Schmidt MK, Ausems M, Garcia EBG, van de Beek I, Wevers MR, Evans DG, Tischkowitz M, Lalloo F, Cook J, Izatt L, Tripathi V, Snape K, Musgrave H, Sharif S, Murray J, Colonna SV, Andrulis IL, Daly MB, Southey MC, de la Hoya M, Osorio A, Foretova L, Berkova D, Gerdes AM, Olah E, Jakubowska A, Singer CF, Tan Y, Augustinsson A, Rantala J, Simard J, Schmutzler RK, Milne RL, Phillips KA, Terry MB, Goldgar D, van Leeuwen FE, Mooij TM, Antoniou AC, Easton DF, Rookus MA, Engel C. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast Cancer Res 2023;25:72.
23. Kelly BD, Perera M, Bolton DM, Papa N. Social determinants of health: does socioeconomic status affect access to staging imaging for men with prostate cancer. Prostate Cancer Prostatic Dis 2023;26:429-31.
24. Kostos L, Buteau JP, Hofman MS, Azad AA. Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancer. Ther Adv Med Oncol 2023;15:17588359231179309.
25. Larach JT, Flynn J, Tew M, Fernando D, Apte S, Mohan H, Kong J, McCormick JJ, Warrier SK, Heriot AG. Robotic versus laparoscopic proctectomy: a comparative study of short-term economic and clinical outcomes. Int J Colorectal Dis 2023;38:161.
26. Lawrence MG, Taylor RA, Cuffe GB, Ang LS, Clark AK, Goode DL, Porter LH, Le Magnen C, Navone NM, Schalken JA, Wang Y, van Weerden WM, Corey E, Isaacs JT, Nelson PS, Risbridger GP. The future of patient-derived xenografts in prostate cancer research. Nat Rev Urol 2023;20:371-84.
27. Lawrentschuk N. Editorial Comment. J Urol 2023;210:185.
28. Le KDR, Choy KT, Roth S, Heriot AG, Kong JCH. Immune mediated colitis: a surgical perspective. ANZ J Surg 2023;93:1495-502.
29. Lindsay J, Walti CS, Halpern AB, Xie H, Chung EL, Schonhoff KG, Huebner EM, Cheng GS, Kimball LE, Leisenring WM, Greenwood M, Chen SC, Kong DCM, Slavin MA, Boeckh M, Fredricks DN, Liu C, Pergam SA, Walter RB, Hill JA. Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms. Blood Adv 2023;7:3140-5.
30. Lisy K, Kerr L, Jefford M, Fisher C. "Everything's a fight": A qualitative study of the cancer survivorship experiences of transgender and gender diverse Australians. Cancer Med 2023;12:12739-48.
31. Looman EL, Cheng PF, Lai-Kwon J, Morgan L, Wakkee M, Dummer R, Dimitriou F. Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune checkpoint inhibitors. Cancer Med 2023;12:12861-73.
32. Loong HH, Shimizu T, Prawira A, Tan AC, Tran B, Day D, Tan DSP, Ting FIL, Chiu JW, Hui M, Wilson MK, Prasongsook N, Koyama T, Reungwetwattana T, Tan TJ, Heong V, Voon PJ, Park S, Tan IB, Chan SL, Tan DSW. Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group. ESMO Open 2023;8:101586.
33. Melenotte C, Aimanianda V, Slavin M, Aguado JM, Armstrong-James D, Chen YC, Husain S, Van Delden C, Saliba F, Lefort A, Botterel F, Lortholary O. Invasive aspergillosis in liver transplant recipients. Transpl Infect Dis 2023;25:e14049.
34. Morris R, Keating N, Tan C, Chen H, Laktyushin A, Saiyed T, Liau NPD, Nicola NA, Tiganis T, Kershaw NJ, Babon JJ. Structure guided studies of the interaction between PTP1B and JAK. Commun Biol 2023;6:641.
35. O'Mahony DG, Ramus SJ, Southey MC, Meagher NS, Hadjisavvas A, John EM, Hamann U, Imyanitov EN, Andrulis IL, Sharma P, Daly MB, Hake CR, Weitzel JN, Jakubowska A, Godwin AK, Arason A, Bane A, Simard J, Soucy P, Caligo MA, Mai PL, Claes KBM, Teixeira MR, Chung WK, Lazaro C, Hulick PJ, Toland AE, Pedersen IS, Investigators H, Neuhausen SL, Vega A, de la Hoya M, Nevanlinna H, Dhawan M, Zampiga V, Danesi R, Varesco L, Gismondi V, Vellone VG, James PA, Janavicius R, Nikitina-Zake L, Nielsen FC, van Overeem Hansen T, Pejovic T, Borg A, Rantala J, Offit K, Montagna M, Nathanson KL, Domchek SM, Osorio A, Garcia MJ, Karlan BY, Collaborators GS, De Fazio A, Bowtell D, Group A, McGuffog L, Leslie G, Parsons MT, Dork T, Speith LM, Dos Santos ES, da Costa A, Radice P, Peterlongo P, Papi L, Engel C, Hahnen E, Schmutzler RK, Wappenschmidt B, Easton DF, Tischkowitz M, Singer CF, Tan YY, Whittemore AS, Sieh W, Brenton JD, Yannoukakos D, Fostira F, Konstantopoulou I, Soukupova J, Vocka M, Consortium C, Chenevix-Trench G, Pharoah PDP, Antoniou AC, Goldgar DE, Spurdle AB, Michailidou K, Consortium of Investigators of Modifiers of B, Evidence-based Network for the Interpretation of Germline Mutant Alleles C. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. Br J Cancer 2023;128:2283-94.
36. Pomykala KL, Hadaschik BA, Sartor O, Gillessen S, Sweeney CJ, Maughan T, Hofman MS, Herrmann K. Next generation radiotheranostics promoting precision medicine. Ann Oncol 2023;34:507-19.
37. Ramanan R, Lim ABM, Tan JLC, Barmanray RD, Mason K, Collins J, Hillman M, Szer J, Bajel A, Ritchie D. Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft-versus-host disease prophylaxis following allogeneic haemopoietic cell transplantation. Intern Med J 2023;53:951-60.
38. Rembielak A, Budrukkar A, Kron T. Function Preservation with Brachytherapy: Reviving the Art. Clin Oncol (R Coll Radiol) 2023;35:485-8.
39. Rodger EJ, Gimenez G, Ajithkumar P, Stockwell PA, Almomani S, Bowden SA, Leichter AL, Ahn A, Pattison S, McCall JL, Schmeier S, Frizelle FA, Eccles MR, Purcell RV, Chatterjee A. An epigenetic signature of advanced colorectal cancer metastasis. iScience 2023;26:106986.
40. Sim BZ, Sim BL, Tunbridge MJ, Perkins GB, Chai CS, Coates PT. SARS-CoV-2 seropositivity in renal transplant patients administered intravenous immunoglobulin. Transpl Infect Dis 2023;25:e14016.
41. Smith A, Gao M, Tran M, Ftanou M, Jegathees S, Wu V, Jefford M, Lynch F, Dhillon HM, Shaw J, McDowell L, White A, Halloran C, Wiesenfeld D, Bamgboje-Ayodele A. Evaluation of the validity and screening performance of a revised single-item fear of cancer recurrence screening measure (FCR-1r). Psychooncology 2023;32:961-71.
42. Sutherland DEK, Kashyap R, Jackson P, Buteau JP, Murphy DG, Kelly B, Spain L, Sandhu S, Azad AA, Medhurst E, Kong G, Hofman MS. Safety of Lutetium-177 prostate-specific membrane antigen-617 (PSMA-617) radioligand therapy in the setting of severe renal impairment: a case report and literature review. Ther Adv Med Oncol 2023;15:17588359231177018.
43. Swain M, Budrukkar A, Rembielak A, Kron T, Agarwal JP. Challenges in the Sustainability of Brachytherapy Service in Contemporary Radiotherapy. Clin Oncol (R Coll Radiol) 2023;35:489-96.
44. Teh CE, Peng H, Luo MX, Tan T, Trussart M, Howson LJ, Chua CC, Muttiah C, Brown F, Ritchie ME, Wei AH, Roberts AW, Bryant VL, Anderson MA, Lindeman GJ, Huang DCS, Thijssen R, Gray DHD. Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells. Blood Adv 2023;7:2733-45.
45. Thompson PA, Tam CS. Pirtobrutinib: a new hope for patients with BTK inhibitor-refractory lymphoproliferative disorders. Blood 2023;141:3137-42.
46. Tremblay S, Alhogbani M, Weickhardt A, Davis ID, Scott AM, Hicks RJ, Metser U, Chua S, Davda R, Punwani S, Payne H, Tunariu N, Ho B, Young S, Singbo MNU, Bauman G, Emmett L, Pouliot F. Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial. Cancer Imaging 2023;23:57.
47. van der Kruk SR, Gunn KM, MacDougall H, Milne D, Smith K, Zielinski R. Feasibility and preliminary effectiveness of virtual reality as a patient education tool for people with cancer undergoing immunotherapy: a protocol for a randomised controlled pilot study in a regional setting. BMJ Open 2023;13:e071080.
48. Veen K, Nguyen PK, Froldi F, Dong Q, Alvarez-Ochoa E, Harvey KF, McMullen JP, Marshall O, Jusuf PR, Cheng LY. Dedifferentiation-derived neural stem cells exhibit perturbed temporal progression. EMBO Rep 2023;24:e55837.
49. Villagran Asiares A, Vitadello T, Bogdanovic B, Solari EL, McIntosh L, Schachoff S, Ibrahim T, Nekolla SG. Value of PET ECG gating in a cross-validation study of cardiac function assessment by PET/MR imaging. J Nucl Cardiol 2023;30:1050-60.
50. Waryah C, Alves E, Mazzieri R, Dolcetti R, Thompson EW, Redfern A, Blancafort P. Unpacking the Complexity of Epithelial Plasticity: From Master Regulator Transcription Factors to Non-Coding RNAs. Cancers (Basel) 2023;15.
51. Wei AH, Roberts AW. BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond. Hemasphere 2023;7:e912.
52. Wei G, Ranasinghe W, Evans M, Bolton D, Dodds L, Frydenberg M, Kearns P, Lawrentschuk N, Murphy DG, Millar J, Papa N. Decade-long trends in prostate cancer biopsy grade groups and treatment within a population-based registry. BJU Int 2023;131 Suppl 4:36-42.
53. Yenson VM, Amgarth-Duff I, Brown L, Caperchione CM, Clark K, Cross A, Good P, Landers A, Luckett T, Philip J, Steer C, Vardy JL, Wong AK, Agar MR. Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian/New Zealand modified Delphi study. Support Care Cancer 2023;31:436.
54. Zhong Y, McKenna L, Copnell B, Zhao W, Moss C. Professional Adaptation Experiences of Chinese Migrant Nurses in Australia: A Qualitative Study. West J Nurs Res 2023;45:626-33.